21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study

To present the outcome and toxicity results of a prospective trial of 21 Gy single fraction high-dose-rate (HDR) brachytherapy for men with low- or intermediate-risk prostate cancer.

Source: Brachytherapy - March 20, 2024 Category: Cancer & Oncology Authors: Kamran Salari, Allison J. Hazy, Hong Ye, Evelyn Sebastian, Amy Limbacher, Matthew Johnson, Beth Mitchell, Andrew B. Thompson, Zachary A. Seymour, Sirisha R. Nandalur, Daniel J. Krauss Source Type: research